01466nam 2200385Ia 450 991069812710332120090324130955.0(CKB)5470000002395712(OCoLC)316867708(EXLCZ)99547000000239571220090324d2008 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] contents of a complete submission for the evaluation of proprietary namesSilver Spring, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) ;Rockville, MD :Center for Biologics Evaluation and Research (CBER),[2008]i, 17 pages digital, PDF fileTitle from PDF title page (viewed on Mar. 24, 2009)."Draft guidance.""November 2008."Guidance for industry DrugsLabelingEvaluationBrand name productsEvaluationDrugsLabelingEvaluation.Brand name productsEvaluation.Center for Drug Evaluation and Research (U.S.)Center for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910698127103321Guidance for industry3434577UNINA